Biosimilar

Biosimilars can provide the same positive outcomes for patients as their reference biologics, but at lower costs. By offering more affordable alternatives, biosimilars expand access to life-changing treatments globally.

With state-of-the-art analytical capabilities to thoroughly demonstrate biosimilarity during development, IVY Pharma is committed to developing biosimilars that are just as safe and effective as branded biologics. Our partnerships and licensing opportunities aim to expand patient access to these important medicines globally.

Partnerships and Licensing

Active seeking of partners is underway for collaboration on developing, manufacturing, and commercializing biosimilars globally across all phases of development.

Please contact us to learn more about biosimilar licensing and collaboration opportunities. Together, we can expand patient access worldwide.